Biosimilars: recent legal and regulatory developments
The true impact of biosimilars is starting to be felt across the industry
Read More
Search Results for: Mark Fish
UK synthetic antibody firm raises £1.5m
A UK-based life sciences group developing synthetic alternatives to antibodies has raised investment of £1.5 million to help advance its business.
Read More
Cytox gets £800,00 from Innovate UK
Cytox has been awarded funding from Innovate UK for the clinical evaluation of its pioneering approach to Alzheimer’s disease risk assessment.
Read More
Patient Files: Hepatitis C
Mark Brunning’s hepatitis C is now under control, but at its worst the disease felt like “death from a thousand cuts”
Read More- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
